Platelet-activating factor: A role in preterm delivery and an essential interaction with toll-like receptor signaling in mice

Biology of Reproduction

Volumn 91, Issue 5, 2014, Pages

  Agrawal, Varkha ^a   Jaiswal, Mukesh Kumar ^b   Ilievski, Vladimir ^a   Beaman, Kenneth D ^b   Jilling, Tamas ^c   Hirsch, Emmet ^a,d  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cytokines; Escherichia coli; Inflammation; Macrophages

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; I KAPPA B KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MYELOID DIFFERENTIATION FACTOR 88; RANTES; THROMBOCYTE ACTIVATING FACTOR; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR; 1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; MYD88 PROTEIN, MOUSE; TICAM-1 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME DEGRADATION; FEMALE; INNATE IMMUNITY; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PREMATURE LABOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C3H MOUSE; C57BL MOUSE; CELL CULTURE; EPISTASIS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; PREMATURITY;

ESCHERICHIA COLI; MUS;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; CELLS, CULTURED; EPISTASIS, GENETIC; FEMALE; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; PLATELET ACTIVATING FACTOR; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREMATURE BIRTH; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84925349033     PISSN: 00063363     EISSN: 15297268     Source Type: Journal    
DOI: 10.1095/biolreprod.113.116012     Document Type: Article

References (58)

1. The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 2008; 32: 100-106.
2. Kravchenko VV, Pan Z, Han J, Herbert JM, Ulevitch RJ, Ye RD. Plateletactivating factor induces NF-kappa B activation through a G proteincoupled pathway. J Biol Chem 1995; 270:14928-14934.
3. Zimmerman GA, McIntyre TM, Prescott SM, Otsuka K. Brief review: molecular mechanisms of neutrophil binding to endothelium involving platelet-activating factor and cytokines. J Lipid Mediat 1990; 2(Suppl): S31-S43.
4. Bito H, Honda Z, Nakamura M, Shimizu T. Cloning, expression and tissue distribution of rat platelet-activating-factor-receptor cDNA. Eur J Biochem 1994; 221:211-218.
5. Bito H, Sakanaka C, Takano T, Kudo Y, Shimizu T. Molecular cloning of a novel type of somatostatin receptor and platelet-activating factor receptor cDNAs from rat. Ann N Y Acad Sci 1993; 707:480-481.
6. Qiu ZH, Leslie CC. Protein kinase C-dependent and -independent pathways of mitogen-activated protein kinase activation in macrophages by stimuli that activate phospholipase A2. J Biol Chem 1994; 269: 19480-19487.
7. Oka S, Arita H. Inflammatory factors stimulate expression of group II phospholipase A2 in rat cultured astrocytes: two distinct pathways of the gene expression. J Biol Chem 1991; 266:9956-9960.
8. Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 1998; 273:4012-4020.
9. Maul H, Shi L, Marx SG, Garfield RE, Saade GR. Local application of platelet-activating factor induces cervical ripening accompanied by infiltration of polymorphonuclear leukocytes in rats. Am J Obstet Gynecol 2002; 187:829-833.
10. Sugano T, Narahara H, Nasu K, Arima K, Fujisawa K, Miyakawa I. Effects of platelet-activating factor on cytokine production by human uterine cervical fibroblasts. Mol Hum Reprod 2001; 7:475-481.
11. Sugano T, Nasu K, Narahara H, Kawano Y, Nishida Y, Miyakawa I. Platelet-activating factor induces an imbalance between matrix metalloproteinase-1 and tissue inhibitor of metalloproteinases-1 expression in human uterine cervical fibroblasts. Biol Reprod 2000; 62:540-546.
12. Li L, Yasuda K, Matsubara T, Okada H, Nakajima T, Sanezumi M, Kanzaki H. Estrogen effects on platelet-activating factor and plateletactivating factor acetylhydrolase activity in rat uterus during the late stages of pregnancy. Prostaglandins Other Lipid Mediat 1999; 57:219-230.
13. Matsubara T, Yasuda K, Johnston JM, Sanezumi M, Okada H, Matsuoka S, Kanzaki H. Platelet-activating factor (PAF) and PAF acetylhydrolaseactivity in rat uterus and placenta during the late stages of pregnancy. Biol Reprod 1997; 56:885-890.
14. Agrawal V, Hirsch E. Intrauterine infection and preterm labor. Semin Fetal Neonatal Med 2011; 17:12-19.
15. Elovitz MA, Wang Z, Chien EK, Rychlik DF, Phillippe M. A new model for inflammation-induced preterm birth: the role of platelet-activating factor and Toll-like receptor-4. Am J Pathol 2003; 163:2103-2111.
16. Thaete LG, Neerhof MG, Jilling T, Caplan MS. Infusion of exogenous platelet-activating factor produces intrauterine growth restriction in the rat. J Soc Gynecol Investig 2003; 10:145-150.
17. Neerhof MG, Khan S, Synowiec S, Qu XW, Thaete LG. The significance of endothelin in platelet-activating factor-induced fetal growth restriction. Reprod Sci 2012; 19:1175-1180.
18. Hoffman DR, Romero R, Johnston JM. Detection of platelet-activating factor in amniotic fluid of complicated pregnancies. Am J Obstet Gynecol 1990; 162:525-528.
19. Silver RK, Caplan MS, Kelly AM. Amniotic fluid platelet-activating factor (PAF) is elevated in patients with tocolytic failure and preterm delivery. Prostaglandins 1992; 43:181-187.
20. Takeda K, Akira S. TLR signaling pathways. Semin Immunol 2004; 16: 3-9.
21. Ilievski V, Lu SJ, Hirsch E. Activation of Toll-like receptors 2 or 3 and preterm delivery in the mouse. Reprod Sci 2007; 14:315-320.
22. Knapp S, von Aulock S, Leendertse M, Haslinger I, Draing C, Golenbock DT, van der Poll T. Lipoteichoic acid-induced lung inflammation depends on TLR2 and the concerted action of TLR4 and the platelet-activating factor receptor. J Immunol 2008; 180:3478-3484.
23. Jaiswal MK, Agrawal V, Mallers T, Gilman-Sachs A, Hirsch E, Beaman KD. Regulation of apoptosis and innate immune stimuli in inflammationinduced preterm labor. J Immunol 2013; 191:5702-5713.
24. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282:2085-2088.
25. Filipovich Y, Lu SJ, Akira S, Hirsch E. The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am J Obstet Gynecol 2009; 200:93 e91-98.
26. Wang H, Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of Tolllike receptor 4. Biol Reprod 2003; 69:1957-1963.
27. Lu J, Pierce M, Franklin A, Jilling T, Stafforini DM, Caplan M. Dual roles of endogenous platelet-activating factor acetylhydrolase in a murine model of necrotizing enterocolitis. Pediatr Res 2010; 68:225-230.
28. Gonzalez JM, Franzke CW, Yang F, Romero R, Girardi G. Complement activation triggers metalloproteinases release inducing cervical remodeling and preterm birth in mice. Am J Pathol 2011; 179:838-849.
29. Mussalli GM, Blanchard, R, Brunnert, SR, Hirsch, E. Inflammatory cytokines in a murine model of infection-induced preterm labor: cause or effect? J Soc Gynecol Invest 1999; 6.
30. Ding AH, Nathan, CF. Trace levels of bacterial lipopolysaccharide prevent interferon-gamma or tumor necrosis factor-alpha from enhancing mouse peritoneal macrophage respiratory burst capacity. J Immunol 1987; 139: 1971-1977.
31. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11:115-122.
32. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, Takeuchi O, Sugiyama M, Okabe M, Takeda K, Akira S. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301:640-643.
33. Ishii S, Shimizu T. Platelet-activating factor (PAF) receptor and genetically engineered PAF receptor mutant mice. Prog Lipid Res 2000; 39:41-82.
34. Ilievski V, Hirsch E. Synergy between viral and bacterial Toll-like receptors leads to amplification of inflammatory responses and preterm labor in the mouse. Biol Reprod 2010; 83:767-773.
35. Zhao TZ, Xia YZ, Li L, Li J, Zhu G, Chen S, Feng H, Lin JK. Bovine serum albumin promotes IL-1beta and TNF-alpha secretion by N9 microglial cells. Neurol Sci 2009; 30:379-383.
36. Daniels I, Cavill D, Murray IA, Long RG. Elevated expression of iNOS mRNA and protein in coeliac disease. Clin Chim Acta 2005; 356: 134-142.
37. Hirsch E, Blanchard R, Mehta SP. Differential fetal and maternal contributions to the cytokine milieu in a murine model of infectioninduced preterm birth. Am J Obstet Gynecol 1999; 180:429-434.
38. Hirsch E, Saotome I, Hirsh D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995; 172:1598-1603
39. Hirsch E, Filipovich Y, Mahendroo M. Signaling via the type I IL-1 andTNF receptors is necessary for bacterially induced preterm labor in a murine model. Am J Obstet Gynecol 2006; 194:1334-1340.
40. Agrawal V, Smart K, Jilling T, Hirsch E. Surfactant protein (SP)-A suppresses preterm delivery and inflammation via TLR2. PLoS One 2013; 8:e63990.
41. Cuschieri J, Bulger E, Garcia I, Jelacic S, Maier RV. Calcium/calmodulindependent kinase II is required for platelet-activating factor priming. Shock 2005; 23:99-106.
42. Claud EC, Lu J, Wang XQ, Abe M, Petrof EO, Sun J, Nelson DJ, Marks J, Jilling T. Platelet-activating factor-induced chloride channel activation is associated with intracellular acidosis and apoptosis of intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2008; 294:G1191-G1200.
43. Liu X, Yao M, Li N, Wang C, Zheng Y, Cao X. CaMKII promotes TLRtriggered proinflammatory cytokine and type I interferon production by directly binding and activating TAK1 and IRF3 in macrophages. Blood 2008; 112:4961-4970.
44. Tiemann U. The role of platelet-activating factor in the mammalian female reproductive tract. Reprod Domest Anim 2008; 43:647-655.
45. Billah MM, Johnston JM. Identification of phospholipid platelet-activating factor (1-0-alkyl-2-acetyl-sn-glycero-3-phosphocholine) in human amniotic fluid and urine. Biochem Biophys Res Commun 1983; 113:51-58.
46. Nishihira J, Ishibashi T, Imai Y, Muramatsu T. Mass spectrometric evidence for the presence of platelet-activating factor (1-0-alkyl-2-acetylsn-glycero-3-phosphocholine) in human amniotic fluid during labor. Lipids 1984; 19:907-910.
47. Alvi SA, Brown NL, Bennett PR, Elder MG, Sullivan MH. Corticotrophin-releasing hormone and platelet-activating factor induce transcription of the type-2 cyclo-oxygenase gene in human fetal membranes. Mol Hum Reprod 1999; 5:476-480.
48. Morris C, Khan H, Sullivan MH, Elder MG. Effects of platelet-activating factor on prostaglandin E2 production by intact fetal membranes. Am J Obstet Gynecol 1992; 166:1228-1231.
49. Stjernholm-Vladic Y, Stygar D, Mansson C, Masironi B, Akerberg S, Wang H, Ekman-Ordeberg G, Sahlin L. Factors involved in the inflammatory events of cervical ripening in humans. Reprod Biol Endocrinol 2004; 2:74.
50. Maul H, Shi L, Marx SG, Garfield RE, Saade GR. Platelet-activating factor antagonist WEB-2170 inhibits lipopolysaccharide-induced, but notantiprogestin-induced, preterm cervical ripening in timed-pregnant rats. Am J Obstet Gynecol 2003; 189:963-967.
51. Zhu YP, Word RA, Johnston JM. The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. Am J Obstet Gynecol 1992; 166:1222-1227.
52. Tetta C, Montrucchio G, Alloatti G, Roffinello C, Emanuelli G, Benedetto C, Camussi G, Massobrio M. Platelet-activating factor contracts human myometrium in vitro. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine 1986; 183: 376-381.
53. Murasawa S, Mori Y, Nozawa Y, Gotoh N, Shibuya M, Masaki H, Maruyama K, Tsutsumi Y, Moriguchi Y, Shibazaki Y, Tanaka Y, Iwasaka T, et al. Angiotensin II type 1 receptor-induced extracellular signalregulated protein kinase activation is mediated by Ca2{thorn}/calmodulindependent transactivation of epidermal growth factor receptor. Circ Res 1998; 82:1338-1348.
54. Belcheva MM, Szucs M, Wang D, Sadee W, Coscia CJ. mu-Opioid receptor-mediated ERK activation involves calmodulin-dependent epidermal growth factor receptor transactivation.J Biol Chem 2001; 276: 33847-33853.
55. Nilsson UK, Svensson SP. Inhibition of Ca2{thorn}/calmodulin-dependent protein kinase or epidermal growth factor receptor tyrosine kinase abolishes lysophosphatidic acid-mediated DNA-synthesis in human myometrial smooth muscle cells. Cell Biol Int 2003; 27:341-347.
56. Wu CY, Chi PL, Hsieh HL, Luo SF, Yang CM. TLR4-dependent induction of vascular adhesion molecule-1 in rheumatoid arthritis synovial fibroblasts: roles of cytosolic phospholipase A(2)alpha/cyclooxygenase-2. J Cell Physiol 2010; 223:480-491.
57. Shindou H, Hishikawa D, Nakanishi H, Harayama T, Ishii S, Taguchi R, Shimizu T. A single enzyme catalyzes both platelet-activating factor production and membrane biogenesis of inflammatory cells: cloning and characterization of acetyl-CoA:LYSO-PAF acetyltransferase. J Biol Chem 2007; 282:6532-6539.
58. Howard KM, Abdel-Al M, Ditmyer M, Patel N. Lipopolysaccharide and platelet-activating factor stimulate expression of platelet-activating factor acetylhydrolase via distinct signaling pathways. Inflamm Res 2011; 60: 735-744.